Locations:
SearchAdvertisement
New pathways to consider in the treatment of SSc-ILD
Nintedanib significantly reduces loss of lung function
An interview with Daniel Culver, DO
Three clinical trials testing old and new drugs
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Largest trial to date is studying use of nintedanib
Multicenter trial studies use of bardoxolone
Multicenter trial studies use of pirfenidone
![18-PUL-4645-Tolle-Hero-Image-650x450pxl[5]](https://assets.clevelandclinic.org/transform/StoryPanel/d0dfe399-8e94-4a38-a720-258396b54c23/18-PUL-4645-Tolle-Hero-Image-650x450pxl5_jpg?w=3840&q=75)
An overview of available treatment modalities
In recognition of Respiratory Institute’s national expertise
Advertisement
Advertisement
